ÂÜÀòÂÒÂ×

Dr. Thomas Klaue is an accomplished executive with extensive experience in leadership roles across various organizations. Currently serving as CEO of SIQENS GmbH since July 2022 and CFO of sterna biologicals GmbH since January 2022, Dr. Klaue has previously held CEO positions at boneArtis AG and Injex Pharma Group, along with financial leadership roles as CFO at Marseille Kliniken AG and MediGene AG. Dr. Klaue's background also includes a Vice President role at Infineon Technologies. Educational qualifications encompass a PMD from Harvard Business School, a Visiting Scholar status at the Massachusetts Institute of Technology, a PhD in Business Economics from the University of Mannheim, and a Master's degree in Engineering from Karlsruhe Institute of Technology.